1-[3-[4-(2-chlorophenyl)-5-pyrimidin-2-yl-1,2,4-triazol-3-yl]cyclobutyl]-2-oxo-3H-benzimidazole-5-carbonitrile

ID: ALA4634574

PubChem CID: 156009696

Max Phase: Preclinical

Molecular Formula: C24H17ClN8O

Molecular Weight: 468.91

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N#Cc1ccc2c(c1)[nH]c(=O)n2[C@H]1C[C@H](c2nnc(-c3ncccn3)n2-c2ccccc2Cl)C1

Standard InChI:  InChI=1S/C24H17ClN8O/c25-17-4-1-2-5-19(17)33-22(30-31-23(33)21-27-8-3-9-28-21)15-11-16(12-15)32-20-7-6-14(13-26)10-18(20)29-24(32)34/h1-10,15-16H,11-12H2,(H,29,34)/t15-,16-

Standard InChI Key:  QNPJJFUGIXURAN-WKILWMFISA-N

Molfile:  

 
     RDKit          2D

 34 39  0  0  0  0  0  0  0  0999 V2000
   35.4831   -6.8323    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.8167   -6.3475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0686   -5.5636    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.8935   -5.5636    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.1495   -6.3475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9469   -6.5611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6731   -6.1406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0837   -6.8579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3575   -7.2743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8811   -7.0673    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.5221   -6.5505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2148   -7.0008    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.9973   -7.7976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1743   -7.8384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7997   -8.5767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2555   -9.2649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0724   -9.2176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4492   -8.4836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4871   -9.9347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8976  -10.6477    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.5221   -5.7254    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.0193   -6.5611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8054   -7.3585    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.0112   -7.5701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4271   -6.9860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6369   -6.1936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4318   -5.9736    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.4831   -7.6573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1960   -8.0681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1949   -8.8897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4816   -9.3045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7685   -8.8947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7657   -8.0703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9089   -7.6577    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  6  5  1  6
  7  6  1  0
  8  7  1  0
  8  9  1  0
  9  6  1  0
  8 10  1  1
 11 10  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 13 18  1  0
 19 17  1  0
 19 20  3  0
 11 21  2  0
 22  2  1  0
 23 22  2  0
 24 23  1  0
 25 24  2  0
 26 25  1  0
 27 26  2  0
 22 27  1  0
 28  1  1  0
 29 28  2  0
 30 29  1  0
 31 30  2  0
 32 31  1  0
 33 32  2  0
 28 33  1  0
 29 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4634574

    ---

Associated Targets(Human)

TNKS2 Tchem Tankyrase 1/2 (384 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.91Molecular Weight (Monoisotopic): 468.1214AlogP: 4.01#Rotatable Bonds: 4
Polar Surface Area: 118.07Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.73CX Basic pKa: 0.33CX LogP: 3.92CX LogD: 3.92
Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.43Np Likeness Score: -1.58

References

1. Waaler J, Leenders RGG, Sowa ST, Alam Brinch S, Lycke M, Nieczypor P, Aertssen S, Murthy S, Galera-Prat A, Damen E, Wegert A, Nazaré M, Lehtiö L, Krauss S..  (2020)  Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor.,  63  (13): [PMID:32511917] [10.1021/acs.jmedchem.0c00208]

Source